My Locations
Part of the Duke Cancer Institute
About Me
As a cancer doctor, I strive to provide the kind of care that I would want for my own family. My aim is to use my expertise, knowledge, and understanding of the human condition to empower patients. While scientific knowledge and approaches are at the core of what I do, I find it important to aim to integrate the human context into what my team and I offer patients and their families. Having lived, trained, and worked in different countries, including Australia, the United Kingdom, the Netherlands, and the United States, I have developed unique insights into the practice of medicine and cancer care around the world. These experiences have given me a broader perspective and helped inform my approach to individualized patient care. I see my ability to help patients as a privilege, and I do get enormous pleasure from being able to help. When not working, I am an avid reader and enjoy running, cycling, and spending time with my family.
- Professor of Neurosurgery, Neurosurgery 2020
- Professor in Pharmacology and Cancer Biology, Pharmacology & Cancer Biology 2024
- Professor in Integrative Immunobiology, Integrative Immunobiology 2023
Call for an Appointment
Areas of Expertise
Ratings and Reviews
The ratings and reviews are based on patient responses to the overall provider rating question from the survey. The question reads: “Using any number from 0 to 10, where 0 is the worst provider possible and 10 is the best provider possible, what number would you use to rate this provider?” Responses are converted to a 5-point rating system and applied consistently to all providers. Learn more about our survey process. Patients who see some types of providers receive a different version of the patient satisfaction survey. Those results are not available on DukeHealth.org.
Training and Education
In the News
Loading
Loading
Loading
Loading
Loading
Loading
Clinical Focus and Research
-
A window of opportunity study of Patritumab Deruxtecan in patients with brain metastasesIRB# PRO00109490 , NCT# NCT05620914
-
Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)IRB# PRO00110628 , NCT# NCT05634707
-
PuMP: Oncolytic HSV1 MVR-C5252 in Patients with rHGG (Recurrent Glioma)IRB# PRO00112883 , NCT# NCT06126744
-
MOAB Trial: Optimal Atezolizumab for rGBM (Recurrent Glioblastoma)IRB# PRO00113395 , NCT# NCT06069726
- Glioblastoma Immunotherapy Advancement with Nivolumab and Relatlimab awarded by Bristol-Myers Squibb Company 2024 - 2029
- NUTMEG Tissue Analysis awarded by University of Sydney 2022 - 2028
- Zhang, Kenan, Mehdi Touat, and Mustafa Khasraw. “KL-50: A novel therapeutic agent targeting MGMT-deficient glioblastoma.” Neuro Oncol 27, no. 3 (March 7, 2025): 652–53. https://doi.org/10.1093/neuonc/noaf001.
- Long, Georgina V., Elena Shklovskaya, Laveniya Satgunaseelan, Yizhe Mao, Inês Pires da Silva, Kristen A. Perry, Russell J. Diefenbach, et al. “Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.” Nat Med, February 27, 2025. https://doi.org/10.1038/s41591-025-03512-1.
- Ozair, Ahmad, Hannah Wilding, Debarati Bhanja, Nicholas Mikolajewicz, Michael Glantz, Stuart A. Grossman, Arjun Sahgal, et al. “Leptomeningeal metastatic disease: new frontiers and future directions.” Nat Rev Clin Oncol 22, no. 2 (February 2025): 134–54. https://doi.org/10.1038/s41571-024-00970-3.
- Khasraw, M., A. Noy, M. Gilbert, and A. Omuro. “Neurological complications of non-hodgkin lymphoma.” In Lymphoma and Leukemia of the Nervous System, 267–85, 2012. https://doi.org/10.1007/9781441976680_16.
- Khasraw, Mustafa, and Yasmin Khakoo. “Paraneoplastic Syndromes Affecting the Nervous System.” In Swaiman’s Pediatric Neurology, 1388–94. Elsevier, 2012. https://doi.org/10.1016/b978-1-4377-0435-8.00101-3.
- Khasraw, Mustafa, Ariela Noy, Mark Gilbert, and Antonio Omuro. “Neurological Complications of Non-Hodgkin Lymphoma.” In Lymphoma and Leukemia of the Nervous System, 267–85. Springer New York, 2012. https://doi.org/10.1007/978-1-4419-7668-0_16.
- Phillips, C., M. B. Pinkham, A. Moore, J. Sia, R. L. Jeffree, M. Khasraw, A. Kam, M. Bressel, and A. Haworth. “Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02).” In Breast, Vol. 74, 2024. https://doi.org/10.1016/j.breast.2024.103675.
- Kim, J. Y., J. C. Dalton, N. Cort, J. E. Herndon, M. L. Affronti, K. B. Peters, C. A. Jones, and M. O. Johnson. “Comparing Knowledge and Perceptions of Palliative Care Among Neuro-Oncology Patients, Caregivers, and Providers to a Representative U.S. Sample.” In American Journal of Hospice and Palliative Medicine, 2024. https://doi.org/10.1177/10499091241280610.
- Harrison, Rebecca A., Nazanin K. Majd, Margaret O. Johnson, Diana L. Urbauer, Vinay Puduvalli, and Mustafa Khasraw. “Characterization of industry relationships in oncology.” In Cancer, 129:2848–55, 2023. https://doi.org/10.1002/cncr.34852.
Insurance Accepted
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
-
Aetna
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Assure Plan (HMO D-SNP)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Value Plan (HMO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Aetna/CVS Health
-
Ambetter
- Ambetter of North Carolina
-
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
-
*Duke HomeCare and Hospice does not participate in the plan.
-
Cigna
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
-
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
-
Duke Group Plans
- Duke Basic
- Duke Select
-
Experience Health
- Experience Health Medicare Advantage (HMO) Plan
- Gateway Health Alliance
- Healthgram
-
Humana
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- MedCost
-
Medicare
- First Medicare Direct
- Medicare Part A
- Medicare Part B
-
NC Medicaid
- AmeriHealth Caritas North Carolina
- Carolina Complete Health
- Healthy Blue
- NC Medicaid Direct
- WellCare of North Carolina
-
TRICARE
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
-
United Healthcare
- AARP Medicare Advantage Plan 2 (HMO-POS)
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)**
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare Option PPO
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Healthcare Shared Services - Harvard Pilgrim/UHC Options PPO Network
- United Medical Resources (UMR)
-
*Duke HomeCare and Hospice and mental health providers do not participate with the plan.
-
**Duke Health does not participate in UHC plans on the Health Insurance Marketplace.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
External Relationships
- AnHeart
- BPG Bio
- George Clinical
- Jax lab for genomic research
- Menarini Ricerche S.p.A.
- Servier
- Siren Biotech
- The University of Sydney